Skip to content

Subscriptions are live.

Plans

Why is $DBVT stock moving today?

DBV Technologies S.A. American Depositary Shares · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Why is $DBVT moving today?

The likely driver

No single headline stands out yet. The move may be technical or sector-driven. Check the full $DBVT page for the latest news and filings.

Price
$8.88
Move today
+0.0%
Volume vs avg
0.0x
Scanner alerts today
0
Flagged in 30 days
50
Market cap
$558M
Prev close
$8.88
Avg volume
347K

Nothing has triggered on DBVT yet in this session. Our scanner has flagged it 50 times in the last 30 days , most recently on October 14 for big percentage moves, unusual volume, which is why this page is here. See the full DBVT page for the chart and the alert history.

Earlier scanner activity on DBVT

  • Oct 14Unusual volume (RVOL) alert
  • Oct 13Unusual volume (RVOL) alert
  • Oct 13Unusual volume (RVOL) alert
  • Oct 13Unusual volume (RVOL) alert
  • Oct 12Big % mover alert
  • Oct 12Unusual volume (RVOL) alert
  • Oct 12Unusual volume (RVOL) alert
  • Oct 12Unusual volume (RVOL) alert
  • Oct 12Big % mover alert
  • Oct 9Big % mover alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $DBVT alerts the moment volume spikes

Our scanner flagged $DBVT 50 times in the last 30 days. Create a free account to track $DBVT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.